JINGXIN(002020) 新浪财经·2025-04-03 01:07Group 1 - The core viewpoint of the news is the disclosure of institutional and public fund holdings in Jingxin Pharmaceutical, indicating a slight decrease in the proportion of holdings among the top institutional investors compared to the previous quarter [1][2] Group 2 - As of April 2, 2025, a total of 236 institutional investors hold shares in Jingxin Pharmaceutical, with a combined holding of 228 million shares, accounting for 26.46% of the total share capital [1] - The top ten institutional investors collectively hold 22.43% of the shares, which is a decrease of 2.15 percentage points from the previous quarter [1] Group 3 - In the public fund sector, three funds increased their holdings, while six funds reduced their holdings, with a total decrease of 0.27% [2] - A total of 224 new public funds were disclosed this period, including several focused on innovative drugs and medical investments [2] - One foreign fund, Hong Kong Central Clearing Limited, reduced its holdings by 1.90% compared to the previous quarter [2]